Senate negotiators reach $10 billion COVID funding deal, without global vaccine funds

Mitt Romney
(Image credit: Kevin Dietsch/Getty Images)

Senate Majority Leader Chuck Schumer (D-N.Y.) and Sen. Mitt Romney (R-Utah) on Monday announced a $10 billion deal to fund COVID-19 treatments, vaccines, and related domestic tools to fight the pandemic. But the deal, lower than the $22.5 billion requested by the White House, doesn't contain funds for helping other countries fight the pandemic, slightly complicating the deal's passage through the Democratic-controlled House.

Romney, the top GOP negotiator, said the package would address America's "urgent COVID needs" and highlighted that it "will not cost the American people a single additional dollar," since the funds were repurposed from previous COVID-19 relief packages. Schumer, the lead Democratic bargainer, said that "while we were unable to reach an agreement on international aid in this new agreement, many Democrats and Republicans are committed to pursuing a second supplemental later this spring."

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
To continue reading this article...
Continue reading this article and get limited website access each month.
Get unlimited website access, exclusive newsletters plus much more.
Cancel or pause at any time.
Already a subscriber to The Week?
Not sure which email you used for your subscription? Contact us
Peter Weber, The Week US

Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.